Terms: = Lung cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715
207 results:
1. Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations.
Hong DS; Cappuzzo F; Chul Cho B; Dowlati A; Hussein M; Kim DW; Percent I; Christensen JG; Morin J; Potvin D; Faltaos D; Tassell V; Der-Torossian H; Chao R
Lung Cancer; 2024 Apr; 190():107512. PubMed ID: 38417277
[TBL] [Abstract] [Full Text] [Related]
2. The innovative checkpoint inhibitors of lung adenocarcinoma, cg09897064 methylation and ZBP1 expression reduction, have implications for macrophage polarization and tumor growth in lung cancer.
Wang A; Zheng WS; Luo Z; Bai L; Zhang S
J Transl Med; 2024 Feb; 22(1):173. PubMed ID: 38369516
[TBL] [Abstract] [Full Text] [Related]
3. cebpa facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract] [Full Text] [Related]
4. Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway.
Zhang F; Qi Y; Li J; Liu B; Liu Z; Cui X
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131250
[TBL] [Abstract] [Full Text] [Related]
5. Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.
Sui Q; Hu Z; Liang J; Lu T; Bian Y; Jin X; Li M; Huang Y; Yang H; Wang Q; Lin Z; Chen Z; Zhan C
Cancer Lett; 2024 Jan; 581():216497. PubMed ID: 38008395
[TBL] [Abstract] [Full Text] [Related]
6. Future cancer risk after urgent suspected cancer referral in England when cancer is not found: a national cohort study.
Scott SE; Gildea C; Nicholson BD; Evans RE; Waller J; Smith D; Purushotham A; Round T
Lancet Oncol; 2023 Nov; 24(11):1242-1251. PubMed ID: 37922929
[TBL] [Abstract] [Full Text] [Related]
7. Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Park K; Sabari JK; Haura EB; Shu CA; Spira A; Salgia R; Reckamp KL; Sanborn RE; Govindan R; Bauml JM; Curtin JC; Xie J; Roshak A; Lorenzini P; Millington D; Thayu M; Knoblauch RE; Cho BC
Lung Cancer; 2023 Apr; 178():166-171. PubMed ID: 36868177
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of Maternal Infection During Pregnancy and Childhood Leukemia Among Offspring in Denmark.
He JR; Yu Y; Fang F; Gissler M; Magnus P; László KD; Ward MH; Paltiel O; Tikellis G; Maule MM; Qiu X; Du J; Valdimarsdóttir UA; Rahimi K; Wiemels JL; Linet MS; Hirst JE; Li J; Dwyer T
JAMA Netw Open; 2023 Feb; 6(2):e230133. PubMed ID: 36808241
[TBL] [Abstract] [Full Text] [Related]
9. In vitro antioxidant, anti-inflammatory, and anticancer activities of mixture Thai medicinal plants.
Jongrungraungchok S; Madaka F; Wunnakup T; Sudsai T; Pongphaew C; Songsak T; Pradubyat N
BMC Complement Med Ther; 2023 Feb; 23(1):43. PubMed ID: 36765341
[TBL] [Abstract] [Full Text] [Related]
10. Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell lung cancer and Other Advanced Solid Tumors.
Kollmannsberger C; Hurwitz H; Bazhenova L; Cho BC; Hong D; Park K; Reckamp KL; Sharma S; Der-Torossian H; Christensen JG; Faltaos D; Potvin D; Tassell V; Chao R; Shapiro GI
Target Oncol; 2023 Jan; 18(1):105-118. PubMed ID: 36459255
[TBL] [Abstract] [Full Text] [Related]
11. Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo.
Hlatky MA; Gonzalez PE; Manson JE; Buring JE; Lee IM; Cook NR; Mora S; Bubes V; Stone NJ
JAMA Cardiol; 2023 Jan; 8(1):74-80. PubMed ID: 36416841
[TBL] [Abstract] [Full Text] [Related]
12. Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence.
Bowes K; Jovanoski N; Brown AE; Di Maio D; Belleli R; Chadda S; Abogunrin S
Med Oncol; 2022 Oct; 40(1):4. PubMed ID: 36308605
[TBL] [Abstract] [Full Text] [Related]
13. Melittin induces ferroptosis and ER stress-CHOP-mediated apoptosis in A549 cells.
Li X; Zhu S; Li Z; Meng YQ; Huang SJ; Yu QY; Li B
Free Radic Res; 2022; 56(5-6):398-410. PubMed ID: 36194238
[TBL] [Abstract] [Full Text] [Related]
14. cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy.
Liu A; Pan W; Zhuang S; Tang Y; Zhang H
Adipocyte; 2022 Dec; 11(1):487-500. PubMed ID: 35941833
[TBL] [Abstract] [Full Text] [Related]
15. Impacts of pleural adhesions on lobectomies for malignant lung tumors.
Kobayashi N; Kawamura T; Yanagihara T; Goto Y; Ichimura H; Sato Y
Gen Thorac Cardiovasc Surg; 2022 Dec; 70(12):1042-1047. PubMed ID: 35739454
[TBL] [Abstract] [Full Text] [Related]
16. Who are the real high-risk patients with pathological T2N0M0 non-small-cell lung cancer that can benefit from adjuvant chemotherapy?
Hou X; Yang MZ; Li JB; Tan ZH; Long H; Fu JH; Zhang LJ; Lin P; Yang HX
ESMO Open; 2022 Jun; 7(3):100508. PubMed ID: 35688064
[TBL] [Abstract] [Full Text] [Related]
17. Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study).
Zhang B; Shi C; Gao Z; Zhong H; Xiong L; Gu A; Wang W; Chu T; Zhang W; Wang H; Zhang X; Zhong R; Han B
BMC Cancer; 2022 Mar; 22(1):294. PubMed ID: 35305596
[TBL] [Abstract] [Full Text] [Related]
18. Montelukast ameliorated pemetrexed-induced cytotoxicity in hepatocytes by mitigating endoplasmic reticulum (ER) stress and nucleotide oligomerization domain-like receptor protein 3 (NLRP3) activation.
Fei Z; Zhang L; Wang L; Jiang H; Peng A
Bioengineered; 2022 Mar; 13(3):7894-7903. PubMed ID: 35291928
[TBL] [Abstract] [Full Text] [Related]
19.
Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H
Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895
[TBL] [Abstract] [Full Text] [Related]
20. Infrared Spectroscopy in Differential Diagnosis of Pulmonary Embolism.
Krasnikova OV; Nemirova SV; Medvedev AP; Gordetsov AS
Sovrem Tekhnologii Med; 2021; 12(3):64-69. PubMed ID: 34795981
[TBL] [Abstract] [Full Text] [Related]
[Next]
